Login
$AZN
$172.06 +$0.57 (0.33%) Close

Insider Transactions

What AstraZeneca PLC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 1 1
Sells 0 1
Total trades 4 9

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

Common stock only — 9 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Sharma Mani See remarks Oct 06 Grant / award · A +2 $159.80 +$320 19,291
Sharma Mani See Remarks Sep 08 Grant / award · A +1 $162.60 +$163 19,289
Sharma Mani See Remarks Aug 08 Open-market buy · P +20 $160.57 +$3.25K 19,288
Sharma Mani SVP, Group Controller Aug 06 Grant / award · A +2 $163.34 +$327 19,267
Sharma Mani See Remarks Jul 06 Grant / award · A +2 $190.43 +$381 19,265
Sharma Mani See Remarks Jun 08 Grant / award · A +1 $179.75 +$180 19,263
Sharma Mani See Remarks May 20 Open-market sale · S −11,893 $185.78 −$2.21M 19,262
Sharma Mani See Remarks May 06 Grant / award · A +1 $186.28 +$186 31,155
Sharma Mani See Remarks Apr 07 Grant / award · A +1 $196.03 +$196 31,154

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support